Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates.

Area of Science:

• Gynecology
• Minimally Invasive Surgery
• Reproductive Medicine

Background:

• Profuse uterine bleeding and myomatous uteri significantly impact women's health.
• Endometrial ablation is a common treatment, but reoperation rates can be high.
• The efficacy of combining myoma coagulation with ablation requires further investigation.

Purpose of the Study:

• To compare hysterectomy rates after endometrial ablation alone versus combined with myoma coagulation.
• To evaluate surgical outcomes for treating uterine bleeding and fibroids.
• To assess the impact of myoma coagulation on subsequent surgery rates.

Main Methods:

• Descriptive study of 118 women undergoing endometrial ablation, endometrial ablation with myoma coagulation, or endometrial resection with myoma coagulation.
• Procedures performed between 1986 and 1995 with follow-up up to ten years.
• Analysis of subsequent surgery and hysterectomy rates, including fibroid volume reduction.

Main Results:

• Endometrial ablation alone resulted in 38% reoperation, with 9.6% hysterectomy.
• Combined endometrial ablation and myoma coagulation (myolysis) showed a 12.5% reoperation rate, with 5.7% hysterectomy.
• Combined therapy significantly reduced reoperation rates compared to ablation alone (P<0.01).

Conclusions:

• Myoma coagulation combined with endometrial ablation reduces subsequent surgery rates in women with symptomatic fibroids and bleeding.
• This combined approach, particularly with endometrial resection, lowers the need for hysterectomy.
• Myolysis offers a viable alternative to hysterectomy for managing symptomatic uterine fibroids and bleeding.